These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28493631)

  • 41. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE; Calderon M; Milani M
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Six Different Allergen Extracts for Subcutaneous Specific Immunotherapy in Children: An Open-Labelled, Prospective, Controlled Observational Trial.
    Kopp MV; König IR; Friedrichs F; Umpfenbach HU; Niggemann B; Millner-Uhlemann M
    Int Arch Allergy Immunol; 2019; 180(4):284-290. PubMed ID: 31665735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis.
    Nayak AS; Atiee GJ; Dige E; Maloney J; Nolte H
    Allergy Asthma Proc; 2012; 33(5):404-10. PubMed ID: 23026182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.
    Dahl R; Kapp A; Colombo G; de Monchy JG; Rak S; Emminger W; Rivas MF; Ribel M; Durham SR
    J Allergy Clin Immunol; 2006 Aug; 118(2):434-40. PubMed ID: 16890769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
    Didier A; Worm M; Horak F; Sussman G; de Beaumont O; Le Gall M; Melac M; Malling HJ
    J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.
    Durham SR; Emminger W; Kapp A; Colombo G; de Monchy JG; Rak S; Scadding GK; Andersen JS; Riis B; Dahl R
    J Allergy Clin Immunol; 2010 Jan; 125(1):131-8.e1-7. PubMed ID: 20109743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis.
    Calderon MA; Penagos M; Sheikh A; Canonica GW; Durham SR
    Clin Exp Allergy; 2011 Sep; 41(9):1263-72. PubMed ID: 21848759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustained effects of grass pollen AIT.
    Durham SR;
    Allergy; 2011 Jul; 66 Suppl 95():50-2. PubMed ID: 21668855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ragweed sublingual immunotherapy (SLIT) tablets in allergic rhinoconjunctivitis: a systematic review and meta-analysis.
    Dhulipalla S
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):2765-2775. PubMed ID: 35294618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis.
    Kristiansen M; Dhami S; Netuveli G; Halken S; Muraro A; Roberts G; Larenas-Linnemann D; Calderón MA; Penagos M; Du Toit G; Ansotegui IJ; Kleine-Tebbe J; Lau S; Matricardi PM; Pajno G; Papadopoulos NG; Pfaar O; Ryan D; Santos AF; Timmermanns F; Wahn U; Sheikh A
    Pediatr Allergy Immunol; 2017 Feb; 28(1):18-29. PubMed ID: 27653623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
    Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis.
    Röder E; Berger MY; Hop WC; de Groot H; van Wijk RG
    Pediatr Allergy Immunol; 2013 Feb; 24(1):39-48. PubMed ID: 22882319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.
    Ellis AK; Frankish CW; O'Hehir RE; Armstrong K; Steacy L; Larché M; Hafner RP
    J Allergy Clin Immunol; 2017 Aug; 140(2):486-496. PubMed ID: 28236469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: A meta-analysis of randomized controlled trials.
    Feng B; Wu J; Chen B; Xiang H; Chen R; Li B; Chen S
    Am J Rhinol Allergy; 2017 Jan; 31(1):27-35. PubMed ID: 28234149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.
    Creticos PS; Esch RE; Couroux P; Gentile D; D'Angelo P; Whitlow B; Alexander M; Coyne TC
    J Allergy Clin Immunol; 2014 Mar; 133(3):751-8. PubMed ID: 24332263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review.
    Dhami S; Nurmatov U; Pajno GB; Fernandez-Rivas M; Muraro A; Roberts G; Akdis C; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; du Toit G; Ebisawa M; Eigenmann P; Knol E; Makela M; Nadeau KC; O'Mahony L; Papadopoulos N; Poulsen L; Sackesen C; Sampson H; Santos A; van Ree R; Timmermans F; Sheikh A
    Clin Transl Allergy; 2016; 6():24. PubMed ID: 27382460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.